Cargando…
Glutamatergic medications as adjunctive therapy for moderate to severe obsessive-compulsive disorder in adults: a systematic review and meta-analysis
BACKGROUND: Obsessive-compulsive disorder (OCD) is among the most disabling neuropsychiatric conditions characterized by the presence of repetitive intrusive thoughts, impulses, or images (obsessions) and/or ritualized mental or physical acts (compulsions). Serotonergic medications, particularly Sel...
Autores principales: | Hadi, Fatemeh, Kashefinejad, Shayan, Kamalzadeh, Leila, Hoobehfekr, Saba, Shalbafan, Mohammadreza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8569963/ https://www.ncbi.nlm.nih.gov/pubmed/34736541 http://dx.doi.org/10.1186/s40360-021-00534-6 |
Ejemplares similares
-
Effects of Celecoxib Adjunct to Selective Serotonin Reuptake Inhibitors on Obsessive-Compulsive Disorder
por: Shahini, Najmeh, et al.
Publicado: (2021) -
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial
por: Ghobadian, Ala, et al.
Publicado: (2022) -
Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder
por: Ting, Jonathan T, et al.
Publicado: (2008) -
Glutamatergic augmentation strategies in obsessive–compulsive disorder
por: Sheshachala, Karthik, et al.
Publicado: (2019) -
Medical students’ perception of professionalism climate in clinical settings
por: Hoobehfekr, Saba, et al.
Publicado: (2021)